October 7-10 | FIBES Sevilla
Visit us at Booth D28
Asphalion is pleased to announce its participation at the ESGCT Congress 2025. Our experts Chris Mann, Elisa Jiménez, Jon Giblin and Maria Castella will be present at booth D28, ready to address your regulatory requirements in detail. Our team will provide tailored advice, share insights on regulatory strategies, and discuss the latest trends and challenges in the field.
At Asphalion we can elaborate all regulatory, non-clinical, clinical and CMC documentation required during development, registration and life-cycle of ATMPs. In addition, strategic inputs can be given from the very beginning for segmentation/niche indication, conditional approval/fast-track, orphan drug designations, preclinical and clinical development plans with minimum time-to-market.
If you would like to schedule a meeting with our experts in advance, please contact us at [email protected].
We look forward to engaging with you, answering your questions, and identifying solutions that can help accelerate your development programs. Don’t miss the chance to connect with us at booth D28!
